Candriam SCA’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-66,329
Closed -$340K 892
2021
Q3
$340K Hold
66,329
﹤0.01% 803
2021
Q2
$551K Sell
66,329
-39,561
-37% -$334K ﹤0.01% 791
2021
Q1
$1.1M Hold
105,890
0.01% 619
2020
Q4
$1.15M Sell
105,890
-255,262
-71% -$3.15M 0.01% 631
2020
Q3
$4.31M Buy
361,152
+96,138
+36% +$1.29M 0.04% 375
2020
Q2
$4.26M Buy
265,014
+47,638
+22% +$832K 0.05% 366
2020
Q1
$5.23M Buy
217,376
+38
+0% +$816 0.06% 334
2019
Q4
$5.35M Buy
217,338
+105,838
+95% +$1.57M 0.06% 341
2019
Q3
$1.15M Buy
+111,500
New +$1.41M 0.02% 585
2017
Q2
Sell
-192,000
Closed -$3.29M 723
2017
Q1
$3.29M Sell
192,000
-17,000
-8% -$226K 0.06% 349
2016
Q4
$2.53M Buy
209,000
+25,000
+14% +$261K 0.06% 323
2016
Q3
$1.81M Hold
184,000
0.04% 375
2016
Q2
$1.88M Buy
184,000
+24,000
+15% +$268K 0.05% 324
2016
Q1
$1.93M Sell
160,000
-21,000
-12% -$212K 0.05% 329
2015
Q4
$2.9M Buy
181,000
+25,000
+16% +$371K 0.08% 254
2015
Q3
$2.01M Sell
156,000
-6,000
-4% -$121K 0.05% 341
2015
Q2
$3.89M Buy
162,000
+32,000
+25% +$616K 0.08% 276
2015
Q1
$2.44M Buy
130,000
+60,000
+86% +$1.24M 0.05% 361
2014
Q4
$1.32M Buy
+70,000
New +$1.64M 0.03% 413

Other funds holding EPZM